nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A bivalent form of a RBD-specific synthetic antibody effectively neutralizes SARS-CoV-2 variants
|
Kim, Dong-Gun |
|
|
220 |
C |
p. |
artikel |
2 |
An intronic genetic variant of ZHX2 predicts response to pegylated interferon α therapy in HBeAg-positive chronic hepatitis B patients
|
Hou, Jia |
|
|
220 |
C |
p. |
artikel |
3 |
A phenothiazine urea derivative broadly inhibits coronavirus replication via viral protease inhibition
|
Forrestall, Katrina |
|
|
220 |
C |
p. |
artikel |
4 |
Artificial intelligence: Machine learning approach for screening large database and drug discovery
|
Parvatikar, Prachi P. |
|
|
220 |
C |
p. |
artikel |
5 |
ASK1 inhibitors are potential pan-antiviral drugs, which dampen replication of diverse viruses including SARS-CoV2
|
Demian, Wael L. |
|
|
220 |
C |
p. |
artikel |
6 |
A sulfonamide chalcone inhibited dengue virus with a potential target at the SAM-binding site of viral methyltransferase.
|
Cao, Van |
|
|
220 |
C |
p. |
artikel |
7 |
Does a detectable HCV RNA at the end of DAA therapy herald treatment failure?
|
Zarębska-Michaluk, Dorota |
|
|
220 |
C |
p. |
artikel |
8 |
Editorial Board
|
|
|
|
220 |
C |
p. |
artikel |
9 |
Expanding the anti-flaviviral arsenal: Discovery of a baicalein-derived Compound with potent activity against DENV and ZIKV.
|
Putri, Geraldine Nadya |
|
|
220 |
C |
p. |
artikel |
10 |
Fangchinoline inhibits SARS-CoV-2 and MERS-CoV entry
|
Sadhu, Srikanth |
|
|
220 |
C |
p. |
artikel |
11 |
Functional assessments of SARS-CoV-2 single-round infectious particles with variant-specific spike proteins on infectivity, drug sensitivity, and antibody neutralization
|
Su, Wen-Chi |
|
|
220 |
C |
p. |
artikel |
12 |
Generation of whole-porcine neutralizing antibodies of an alphacoronavirus by single B cell antibody technology
|
Wang, Sheng |
|
|
220 |
C |
p. |
artikel |
13 |
Induction of neutralizing antibodies and mucosal IgA through intranasal immunization with the receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit
|
Hsieh, He-Chin |
|
|
220 |
C |
p. |
artikel |
14 |
In vitro evaluation of tropolone absorption, metabolism, and clearance
|
Woodson, Molly E. |
|
|
220 |
C |
p. |
artikel |
15 |
Lung transcriptomics of K18-hACE2 mice highlights mechanisms and genes involved in the MVA-S vaccine-mediated immune response and protection against SARS-CoV-2 infection
|
Gómez-Carballa, Alberto |
|
|
220 |
C |
p. |
artikel |
16 |
Monoglycosylated SARS-CoV-2 receptor binding domain fused with HAstem-scaffolded protein vaccine confers broad protective immunity against SARS-CoV-2 and influenza viruses
|
Wu, Chia-Ying |
|
|
220 |
C |
p. |
artikel |
17 |
Newcastle Disease Virus (NDV)-based vaccine candidate against SARS-CoV-2 Omicron by intranasal immunization
|
Zhang, Qiu-Yan |
|
|
220 |
C |
p. |
artikel |
18 |
Oral delivery of a chitosan adjuvanted COVID-19 vaccine provides long-lasting and broad-spectrum protection against SARS-CoV-2 variants of concern in golden hamsters
|
Wang, Shen |
|
|
220 |
C |
p. |
artikel |
19 |
Proteomic and phosphoproteomic analysis of responses to enterovirus A71 infection reveals novel targets for antiviral and viral replication
|
Lin, Dandan |
|
|
220 |
C |
p. |
artikel |
20 |
SRPKIN-1 as an inhibitor against hepatitis B virus blocking the viral particle formation and the early step of the viral infection
|
Li, Xiaofang |
|
|
220 |
C |
p. |
artikel |